Just how much evidence do we need? The clinical effectiveness and cost effectiveness of pharmacist input at the ward level have recently been assessed in a systematic review and meta-analysis… again. The results showed that regular pharmacist input was most cost effective, reducing length-of-stay (mean = −1.74 days [95% CI: 2.76, −0.72], and increasing patient and/or carer satisfaction (Relative Risk (RR) = 1.49 [1.09, 2.03] at discharge). It seems way past time to simply accept that pharmacist involvement in multidisciplinary teams improves patient safety and satisfaction and is cost-effective when regularly provided throughout the ward stay. Read more here